Typical in vitro models include fibroblast scratch assays, endothelial tube formation assays, and macrophage polarisation studies.
However, their side effects include nausea, abdominal pain, ulcers, osteoporosis, and diabetes (7)
The actin-binding site on thymosin beta-4 has been reported to promote angiogenesis in study models, and thymosin beta-4 is also described in PubMed-indexed literature as involved in cell migration and differentiation
This documentation must come from the prescribing provider and typically needs to specify the clinical reason for compounding, such as: Allergy to an inactive ingredient in the commercial product Need for a dose not available in commercial presentations Documented intolerance to the commercial delivery device Billing compounded tirzepatide through the pharmacy benefit uses standard pharmacy claim formats (NCPDP) with the compounding pharmacy NDC
For example, if you mixed 2 mL of BAC water into a 10 mg vial (creating 5 mg/mL), a 1 mg dose equals 20 units on an insulin syringe
With FDA input pending, the companies are targeting a Phase 3 trial launch in the first half of 2026
